691875-81-7 Usage
General Description
4-(2-Fluorophenyl) piperidine hydrochloride is a chemical compound that belongs to the class of piperidine derivatives. It is commonly used as a pharmaceutical intermediate in the synthesis of various drugs and medications. The compound has a piperidine ring with a 2-fluorophenyl group attached to it, and it forms a stable salt with hydrochloric acid, known as the hydrochloride salt. This salt form is often used to enhance the solubility and stability of the compound in various pharmaceutical formulations. 4-(2-Fluorophenyl) piperidine hydrochloride is known for its potential pharmacological properties and is being studied for its use in the treatment of various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 691875-81-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,1,8,7 and 5 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 691875-81:
(8*6)+(7*9)+(6*1)+(5*8)+(4*7)+(3*5)+(2*8)+(1*1)=217
217 % 10 = 7
So 691875-81-7 is a valid CAS Registry Number.
InChI:InChI=1S/C11H14FN.ClH/c12-11-3-1-9(2-4-11)10-5-7-13-8-6-10;/h1-4,10,13H,5-8H2;1H
691875-81-7Relevant articles and documents
Saturated Nitrogen and N-Acylated Heterocycles Potentiating the Activity of an Active Antibiotic against Mycobacteria
-
Paragraph 0053, (2015/11/16)
The present invention concerns a compound of general formula (I): in which n=0 or 1, R1 represents an optionally substituted alkyl chain, in particular substituted alkyl chain, in particular substituted with fluorine, X is chosen from N and CH, and R2 is
BENZIMIDAZOLYL COMPOUNDS AS POTENTIATORS OF MGLUR2 SUBTYPE OF GLUTAMATE RECEPTOR
-
Page/Page column 69, (2010/11/30)
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.